Prenatal Screening for CMV Primary Infection: A Cost-Utility Model
Prenatal Screening for CMV Primary Infection: A Cost-Utility Model

Prenatal Screening for CMV Primary Infection: A Cost-Utility Model

Obstet Gynecol Surv. 2025 Nov 1;80(11):689-691. doi: 10.1097/01.ogx.0001172288.00818.27.

ABSTRACT

(Abstracted from BJOG 2025;132:805-815) Approximate 1 in 200 neonates in Canada is born with congenital cytomegalovirus (cCMV). CMV is an infection that can cause neurodevelopmental disability in children, including deafness, visual impairment, or cognitive delay.

PMID:41194360 | DOI:10.1097/01.ogx.0001172288.00818.27